Soybean lipoxygenase inhibition: Studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine

Abstract

Soybean lipoxygenase inhibition has been proposed as an in vitro biochemical model for the antiinflammatory action of certain drugs used in the treatment of ulcerative colitis. In an extension of a recent study which showed that therapeutically active compounds, such as sulphasalazine and its colonic metabolite 5-aminosalicylic acid were soybean… (More)
DOI: 10.1007/BF00542139

Topics

Cite this paper

@article{Allgayer1984SoybeanLI, title={Soybean lipoxygenase inhibition: Studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine}, author={Heike Allgayer and Josef Eisenburg and Gustav Paumgartner}, journal={European Journal of Clinical Pharmacology}, year={1984}, volume={26}, pages={449-451} }